Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Endocrine 1Breast 1

Conditions

Adrenocortical Carcinoma 2Prostatic Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

selpercatinib 3Trastuzumab 2Oxaliplatin 2Melphalan 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1sargramostim 1repotrectinib 1pralsetinib 1mercaptoundecahydrododecaborate 1entinostat 1aldesleukin 1Suramin 1Rose Bengal 1Ritonavir 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Patient Navigation 1Paclitaxel 1Molecular Diagnostic Techniques 1Microscopy, Electron 1Leucovorin 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Immunotherapy 1Floxuridine 1Fentanyl 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Suramin × Endocrine × Clear all
NCT00003038 2011-08-03

Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
BreastEndocrineGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡